(19)
(11) EP 1 370 292 A1

(12)

(43) Date of publication:
17.12.2003 Bulletin 2003/51

(21) Application number: 02704280.3

(22) Date of filing: 31.01.2002
(51) International Patent Classification (IPC)7A61K 45/00, A61K 45/06, A61K 39/395, A61P 35/00, A61P 35/02
// A61K39:395, A61K31:70
(86) International application number:
PCT/US0202/620
(87) International publication number:
WO 0206/0484 (08.08.2002 Gazette 2002/32)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 31.01.2001 US 772938
16.05.2001 US 855717
05.11.2001 US 985646

(71) Applicant: Idec Pharmaceuticals Corporation
San Diego, CA 92121 (US)

(72) Inventors:
  • HARIHARAN, Kandasamy
    San Diego, CA 92129 (US)
  • HANNA, Nabil
    Rancho Santa Fe, CA 92067 (US)
  • BRASLAWSKY, Gary, R.
    San Diego, CA 92129 (US)
  • PATHAN, Nuzhat
    San Diego, CA 92129 (US)

(74) Representative: Daniels, Jeffrey Nicholas et al
Page White & Farrer54 Doughty Street
London WC1N 2LS
London WC1N 2LS (GB)

   


(54) USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS